genotoxic compounds can increase cancer incidence by increasInduced cell proliferation is important in the mode of ing proliferation in transformed or intermediate cells.
There is action of many non-genotoxic renal carcinogens. Since Tsc2 evidence that induction of increased cell proliferation can mutant (Eker) rats are genetically predisposed to the increase the risk of developing cancer (3,5,6). Increasing the development of renal cell tumors, they provide a useful proliferation rate of intermediate cells can increase the risk of animal model in which to study the action of renal carcinocancer with time (7). Affecting the kinetics of intermediate gens. Sodium barbital was used as a model non-genotoxic cells is efficient in affecting tumor incidence because small renal carcinogen to test whether a concentration that changes in the rates of cell replication over cell death rates increased renal tubular proliferation without severe can lead to large changes in tumor incidence (7). nephrotoxicity would enhance tumor induction in a heredit-A xenobiotic can promote the development of tumors by ary tumor model. First, a subchronic concentrationseveral mechanisms. Tumor promoters may target initiated response study was conducted in wild-type male Longcells rather than non-initiated parenchymal cells for mitogenesis Evans rats to determine increased cell proliferation without (4, 8) . The parenchymal cell may undergo hyperplasia as a severe nephrotoxicity. Rats were dosed with sodium barbital reparative response to cytotoxicity (4). The initiated cells may in the feed at 0, 50, 250, 500, 1000, 2000 or 4000 p.p.m.
have different growth control mechanisms than non-initiated for 3 or 8 weeks. Cell proliferation within the cortex and cells and their response to mitogens or toxins may be different nephrotoxicity were quantitated. Enhanced proliferation (4). Or, quite possibly, a particular promoter may work through with minimal nephrotoxicity occurred at 500 p.p.m.. A more than one mechanism. second study was conducted in male Tsc2 mutant rats given A rat model of hereditary renal cell cancer was first described sodium barbital in the feed at 0, 100 or 500 p.p.m. from 9
by Eker (9). These hereditary renal tumors are due to a weeks of age to either 6 or 12 months of age. An additional germline mutation in the tumor suppressor tuberous sclerosis group of rats was treated with sodium barbital for 6 2 gene (Tsc2) (10,11). Tsc2 has been shown to be involved in months and then provided control feed until 12 months of the pathogenesis of renal cell carcinoma in humans and rats age. Rats necropsied at 6 months of age had a concentration-(12). The mutation in the Eker rat is an insertion of DNA into dependent increase in preneoplastic and total renal lesions.
the 3Ј-portion of the Tsc2 gene. This insertional mutation Sodium barbital-treated rats necropsied at 12 months of results in premature stopping of transcription and elimination age had numbers of lesions that were not different from of the distal portion of the Tsc2 gene (13,14). Since this is a controls. Total combined preneoplastic and neoplastic germline mutation, all the cells in the kidney are considered lesions in the 6 month, high dose group was the same as initiated in that they already have the first mutation in developthe 12 month control group. These data show that sodium ing a renal cell tumor. barbital caused progression to the stage of spontaneous Sodium barbital (BB) has been used to promote intestinal, renal lesions in Tsc2 mutant rats but did not increase their overall number. These data suggest that enhanced cell hepatic, thyroid, urinary bladder and renal tumor growth in proliferation without significant cytotoxicity exerted a prorats alone or after treatment with various initiators (15-22). motional influence in this hereditary model.
Male F344 rats promoted with 4000 p.p.m. BB in the diet developed renal carcinomas. The promoting effect was evident as a greater incidence of large renal tubular tumors after 52 Introduction weeks treatment. The incidences of dysplastic tubules and preneoplastic lesions were not different between treated and Among the many potential risk factors for developing renal control animals, suggesting that the targets for the promoting cancer in human patients are gender, heredity and diseases activity of BB are the dysplastic lesions that arise from that cause chronic nephritis and regeneration. The risk of proximal tubule epithelium (23, 24) . Rats given BB had a kidney cancer after renal transplantation is 0.3% in men and positive correlation between increased cell proliferation in 0.9% in women, compared with background renal adenocarcinproximal tubules and the degree of nephropathy, with a 2-fold oma rates of 0.01 and 0.004%, respectively (1,2). The risk of increase in proliferation over controls after 52 and 72 weeks treatment (23) .
A total of 14 fields from the renal cortex were analyzed per animal, seven fields from each kidney. Every attempt was made to limit observations to Prolonged estrogen treatment in Tsc2 mutant (Eker) rats
were considered significant at P Ͻ 0.05. proliferation in the absence of severe cytotoxicity is sufficient to were used as a recovery group. The recovery group received 500 p.p.m. BB until 6 months of age and were then placed on the control diet until 12 months increase tumor development in a genetically susceptible animal.
of age. The same exposure conditions and feed analysis methods were used for the chronic study as described above.
Materials and methods
At 6 and 12 months of age the rats were euthanized by pentobarbital anesthesia, exanguinated and necropsied. Kidneys were removed, examined Dose finding study macroscopically, weighed and fixed in 10% buffered formalin. The numbers The purpose of this initial study was to identify the concentration of BB that and sizes of macroscopically visible renal masses were recorded. The kidneys induced no, limited or substantial increases in renal cortical epithelial cell were sectioned mid-sagittaly and placed in separate cassettes. The kidneys proliferation in 6-week-old Tsc2 wild-type male Long-Evans rats. Dose groups were processed by routine methods to paraffin, sectioned at 5 µm and stained were 0, 50, 250, 500, 1000, 2000 and 4000 p.p.m. BB (CAS no. 144-02-5; with hematoxylin and eosin. The kidneys were examined for preneoplastic Sigma Chemical Co., St Louis, MO) in the feed (NIH-07 chow; Zeigler Bros, and neoplastic microscopic renal lesions and severity of nephropathy as Gardener, PA) as the sole food source beginning at 6 weeks of age. Feed was previously described (25). Macroscopic masses and microscopic lesions were analyzed after each batch was made (Table I) . Feed consumption was counted and reported independently of each other. determined twice a week.
Analyses for two types of responses were performed: whether or not there Rats were randomly assigned to treatment groups by weight, six per was any occurrence of each lesion and the number of lesions (multiplicity) treatment group, housed individually in plastic shoe box cages and uniquely that occurred. Fisher's exact test was used for the analysis of presence of a identified. The rats were exposed to a 12 h light/dark cycle with a room lesion. If the overall test was significant, Fisher's exact test was also used to temperature of 72 Ϯ 2°F and humidity of 50 Ϯ 5%. Water and feed were test for significance of relevant treatment subsets. Lesion multiplicity data available ad libitum.
was first square root transformed and then analyzed by one-way ANOVA. If Osmotic minipumps (Alzet, Palo Alto, CA) containing a 20 mg/ml solution the overall F test for equal means was significant, the Tukey-Kramer test for of bromodeoxyuridine (BrdU) (CAS no. 59-14-3; Sigma) in saline were all pairwise comparisons was applied. The significance level for all analyses implanted in the morning 3 days before euthanasia and necropsy to assess was 0.05. alterations in cell proliferation. After 3 or 8 weeks BB treatment, six rats from each dose group were euthanized by pentobarbital anesthesia, exanguinated and then necropsied. The kidneys were examined, weighed and Results fixed in 10% neutral buffered formalin. Kidneys were cut mid-sagittaly and placed in cassettes, each with a section of duodenum for confirmation that
Dose finding study
BrdU was present in the tissues. The kidneys were processed to paraffin by Male Long-Evans rats treated with BB had time-and concentraroutine methods and sectioned at 5 µm. The sections were either stained with tion-dependent increases in labeling indices in the renal cortex hematoxylin and eosin or reacted with anti-BrdU antibody and counterstained with hematoxylin (27) . Corp.,Westchester, PA). Resolution of images was 1024ϫ768 displaying 256 gray levels on a color monitor driven by a Groundhog Graphics VGA card.
for 3 weeks and 250 p.p.m. or greater for 8 weeks (data not shown). The liver also had moderate centrilobular hypertrophy Rats treated for 10.5 months with 100 p.p.m. BB had in rats treated with 500 p.p.m. BB or greater in the feed for 3 significantly increased numbers of macroscopic masses and and 8 weeks. These data, which were used to set doses, total tumors compared with those treated for 4.5 months indicated that a feed concentration of 500 p.p.m. BB would (Tables II and IV) . Rats treated with 500 p.p.m. BB for provide increased cell proliferation in the proximal renal 10.5 months also had significantly increased numbers of tubules with minimum nephrotoxicity. macroscopic masses and significantly more carcinomas, but significantly fewer atypical tubules, compared with those Tumor promotion study treated for 4.5 months (Tables II and V) . Untreated Eker rats had time-dependent significant increases A biologically significant finding in this study was that there in number and incidence of atypical hyperplasias and tumors was no statistically significant difference between the numbers and a significantly increased incidence in macroscopically of rats with lesions or the multiplicity of lesions in any visible masses (Tables II-V) . These data confirm that spontancategory between any of the groups of animals necropsied at eous lesions develop early, grow over time and form tumors 12 months of age (Tables IV and V) . There was no statistically as previously reported. (27) significant difference in any parameter measured between Rats treated for 4.5 months with BB had treatment-related animals treated for 4.5 months with 500 p.p.m. BB and but not concentration-dependent significant increases in incidnecropsied at 6 months of age and any of the groups necropsied ence and number of atypical hyperplasias (Table III) . There at 12 months of age (Tables II-V) . In addition, the recovery was also a significantly greater number of histologically group, treated with 500 p.p.m. BB for 4.5 months and necropidentifiable lesions in rats treated with 500 p.p.m. BB compared sied at 12 months of age, was not different from any of the with controls (Table III) . Rats treated with 500 p.p.m. BB for other groups necropsied at 12 months of age (Tables IV and V) . 4.5 months had significantly more adenomas and more total tumors than those treated with 100 p.p.m. BB (Table III) .
The severity of nephropathy was slightly increased in the Compounds such as BB, which are not directly mutagenic, treatment, merely increasing the numbers of proliferating cells was not sufficient to increase the number of renal tumors rats treated with 500 p.p.m. BB for 10.5 months compared after longer treatment. These data indicate that enhancing with the other groups necropsied at 12 months of age (Table VI) .
proliferation rates without additional cell stressors is not sufficient by itself to increase tumor numbers, even in a Discussion susceptible population. Cancer may develop from chronic exposure to a xenobiotic The present study showed that BB promoted hereditary renal that is not directly mutagenic by increasing the proliferation tumors in rats, but did not increase the multiplicity of tumors of normal or intermediate cells (4,6,7). This increased proliferawithin a rat. The BB treatment caused spontaneous preneotion could increase transition rates from normal to intermediate plastic lesions to grow to a size morphologically consistent or intermediate to malignant genotypes and phenotypes (7). with a diagnosis of tumor more quickly compared with the Xenobiotics that increase the number of proliferating interuntreated control. These tumors were of the same morpholomediate cells without affecting transition rates may increase gical types that have been previously reported for both spontancancer risk with time, and even small changes in the rate of eous and carcinogen-induced renal tumors in Eker rats cell proliferation over cell death rate can lead to large changes (25,26,28). There was no increase in the total numbers of in tumor incidence (7). The Eker rat model of renal cancer has tumors per rat, unlike the response after treatment with the a mutation that allows increased susceptibility and sensitivity to direct acting mutagen dimethylnitrosamine (26) or with severe renal carcinogenesis in all the cells, which means that all the chronic cytotoxicity as seen after estrogen treatment (25). cells in the kidney are intermediate cells because the rats are Tumor development can be enhanced by increasing the born with a proposed initiating mutation in the renal cancer number of cells at risk, such as with a mutagenic event,
process. The concentrations of BB used in the present study increasing the mitotic activity of a tissue resulting in a promoted spontaneous tumors, so that they reached a size decreased opportunity for DNA repair or by a combination of described as adenoma earlier. these events (29, 30) . Cell turnover times are fairly low for Treatment with BB caused a concentration-related significant many organs, such as the kidney, and spontaneous rates of increase in the labeling index in the renal cortex and outer somatic gene mutation are extremely small compared with the medulla of male F344 rats (34). In all the studies using BB as average cell turnover time (31) . DNA replication does not a tumor promoter, there has not been a concentration-dependent have 100% fidelity, resulting in mistakes in critical genes that response for tumor promotion in male rats treated with can lead to tumor formation (3,32). When cells proliferate concentrations ranging from 500 to 4000 p.p.m. (34). All there is a chance that a critical molecular event can occur, concentrations used appeared to have comparable promoting resulting in an increased risk of developing cancer (3,7,32).
activity. Previous studies have shown concentration-and timeThe total number of DNA replications probably has a greater related BB-induced nephrotoxicity (35). BB given at 4000 influence on the tumor process than proliferation rate (32) .
p.p.m. in the feed resulted in a 62-70% incidence of dysplastic The number of cell replications is a function of the proliferation tubules and a 45% incidence in rats treated with 500 p.p.m. rate and the number of cells in the population at risk (3,32).
(35). BB-induced tumor incidence appeared to be time rather In the case of the Eker rat model, all renal epithelial cells are considered to be intermediate cells.
than concentration dependent (35). The present subchronic study supports the previous work showing a concentration
